PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.\', \'European Institute of Oncology IRCCS, Department of Experimental Oncology, Milan, Italy.\', \'Gastroenterology Unit, Duilio Casula Hospital, AOU Cagliari, Cagliari CA, Italy.\', \'Department of Medical Science and Public Health, University of Cagliari, Cagliari CA, Italy.\', \'Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.\', \'Deutsches Zentrum fuer Immuntherapie [DZI], FAU Erlangen-Nuremberg and Universitätsklinikum Erlangen, Ulmenweg, Germany.\', \'Department of Internal Medicine 1, FAU Erlangen-Nuremberg and Universitätsklinikum Erlangen, Ulmenweg. Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ecco-jcc/jjaa237
?:doi
?:hasPublicationType
?:journal
  • Journal of Crohn\'s & colitis
is ?:pmid of
?:pmid
?:pmid
  • 33211810
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all